1. Home
  2. UTI vs PHVS Comparison

UTI vs PHVS Comparison

Compare UTI & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Technical Institute Inc

UTI

Universal Technical Institute Inc

HOLD

Current Price

$37.32

Market Cap

2.3B

Sector

Real Estate

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$34.44

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTI
PHVS
Founded
1965
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
UTI
PHVS
Price
$37.32
$34.44
Analyst Decision
Strong Buy
Buy
Analyst Count
4
11
Target Price
$37.50
$41.82
AVG Volume (30 Days)
816.4K
566.0K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
50.67
N/A
EPS
0.24
N/A
Revenue
$835,616,000.00
N/A
Revenue This Year
$10.15
N/A
Revenue Next Year
$8.32
N/A
P/E Ratio
$157.96
N/A
Revenue Growth
14.05
N/A
52 Week Low
$21.29
$19.12
52 Week High
$51.34
$36.60

Technical Indicators

Market Signals
Indicator
UTI
PHVS
Relative Strength Index (RSI) 36.57 53.49
Support Level $34.53 $24.73
Resistance Level $40.97 $36.60
Average True Range (ATR) 2.85 1.67
MACD -1.30 -0.22
Stochastic Oscillator 8.97 37.92

Price Performance

Historical Comparison
UTI
PHVS

About UTI Universal Technical Institute Inc

Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.

Share on Social Networks: